Abstract
Low severity of GVHD, substantial graft vs tumor (GVT) and slow development of protective immunity are well-documented features of cord blood transplants (CBT). We have evaluated the immune reconstitution of adult recipients of single-unit CBT supported by the coinfusion of third party donor (TPD) mobilized hematopoietic stem cells (MHSC), a procedure—‘dual CB/TPD-MHSC transplant’—that results in early recovery of circulating granulocytes, high rates of CB engraftment and full chimerism. Cumulative recovery of natural killer and B cells at or above the median values of normal controls were 1.0 and 0.76 by the sixth and ninth months. Recovery of T cells was much slower, naive cells lagging behind those of memory and effector (committed) immunophenotypes. Serial analyses of signal joint TCR excision circles showed a general pattern of very low levels by the third month after CBT, followed by recovery to levels persistently similar or higher than those observed before transplantation and in normal controls. Our results are consistent with the clinical observations of substantial GVT effect together with low incidence of serious GVHD and slow development of protective immunity and suggest that thymic function contributes substantially to the recovery of T-cell populations in adults receiving dual CB/TPD-MHSC transplants.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Magro E, Regidor C, Cabrera R, Sanjuan I, Fores R, Garcia-Marco JA et al. Early hematopoietic recovery after single unit unrelated cord blood transplantation in adults supported by co-infusion of mobilized stem cells from a third party donor. Haematologica 2006; 91: 640–648.
Bautista G, Cabrera R, Regidor C, Forés R, García-Marco JA, Ojeda E et al. Cord blood transplants supported by co-infusion of mobilized hematopoietic stem cells from a third party donor. Bone Marrow Transplant 2008 (e-pub ahead of print 13 October 2008; doi:10.1038/bmt.2008.329).
Fernández MN, Regidor C, Cabrera R, Garcia-Marco JA, Fores R, Sanjuan I et al. Unrelated umbilical cord blood transplants in adults: Early recovery of neutrophils by supportive co-transplantation of a low number of highly purified peripheral blood CD34+ cells from an HLA-haploidentical donor. Exp Hematol 2003; 31: 535–544.
Fallen PR, McGreavey L, Madrigal JA, Potter M, Ethell M, Prentice HG et al. Factors affecting reconstitution of the T cell compartment in allogeneic haematopoietic cell transplant recipients. Bone Marrow Transplant 2003; 32: 1001–1014.
Loeffler J, Bauer R, Herbart H, Douek DC, Rauser G, Bader P et al. Quantification of T-cell receptor excision circle DNA using fluorescence resonance energy transfer and the Light Cycler system. J Immunol Methods 2002; 271: 167–175.
Wagner JE, Barker JN, DeFor TE, Baker KS, Blazar BR, Eide C et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002; 100: 1611–1618.
Brunstein CG, Setubal DC, Wagner JE . Expanding the role of umbilical cord blood transplantation. Br J Haematol 2007; 137: 20–35.
D’Arena G, Musto P, Cascavilla N, Di Giorgio G, Fusilli S, Zendoli F et al. Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features. Haematologica 1998; 83: 197–203.
Moretta A, Maccario R, Fagioli F, Giraldi E, Busca A, Montagna D et al. Analysis of immune reconstitution in children undergoing cord blood transplantation. Exp Hematol 2001; 29: 371–379.
Szabolcs P, Niedzwiecki D . Immune reconstitution after unrelated cord blood transplantation. Cytotherapy 2007; 9: 111–122.
Gill J, Malin M, Sutherland J, Gray D, Hollander G, Boyd R . Thymic generation and regeneration. Immunol Rev 2003; 195: 28–50.
Barthlott T, Keller MP, Krenger W, Holländer GA . A short primer on early molecular and cellular events in thymus organogenesis and replacement. Swiss Med Wkly 2006; 136: 23–24.
Thomas-Vaslin V, Altes HK, de Boer RJ, Klatzmann D . Comprehensive assessment and mathematical modeling of T cell population dynamics and homeostasis. J Immunol 2008; 180: 2240–2250.
Junge S, Kloeckener-Gruissem B, Zufferey R, Keisker A, Salgo B, Fauchere JC et al. Correlation between recent thymic emigrants and CD31+ (PECAM-1) CD4+ T cells in normal individuals during aging and in lymphopenic children. Eur J Immunol 2007; 37: 3270–3280.
Kilpatrick RD, Rickabaugh T, Hultin LE, Hultin P, Hausner MA, Detels R et al. Homeostasis of the naive CD4+ T cell compartment during aging. J Immunol 2008; 180: 1499–1507.
Talvensaari K, Clave E, Douay C, Rabian C, Garderet L, Busson M et al. A broad T-cell repertoire diversity and an efficient thymic function indicate a favorable long-term immune reconstitution after cord blood stem cell transplantation. Blood 2002; 99: 1458–1464.
Rauser G, Einsele H, Sinzger C, Wernet D, Kuntz G, Assenmacher M et al. Rapid generation of combined CMV-specific CD4+ and CD8+ T-cell lines for adoptive transfer into recipients of allogeneic stem cell transplants. Blood 2004; 103: 3565–3572.
Cohen G, Carter SL, Weinberg KI, Masinsin B, Guinan E, Kurtzberg J et al. Antigen-specific T-lymphocyte function after cord blood transplantation. Biol Blood Marrow Transplant 2006; 12: 1335–1342.
Parkman R, Cohen G, Carter SL, Weinberg KI, Masinsin B, Guinan E et al. Successful immune reconstitution decreases leukemic relapse and improves survival in recipients of unrelated cord blood transplantation. Biol Blood Marrow Transplant 2006; 12: 919–927.
Komanduri KV, St John LS, de Lima M, McMannis J, Rosinski S, McNiece I et al. Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing. Blood 2007; 110: 4543–4551.
Schöttker B, Feuchtinger T, Schumm M, Klinker E, Handgretinger R, Einsele H et al. Five donors–one recipient: modeling a mosaic of granulocytes, natural killer and T cells from cord-blood and third-party donors. Nat Clin Pract Oncol 2008; 5: 291–295.
Ruggeri L, Mancusi A, Perruccio K, Burchielli E, Martelli MF, Velardi A . Natural killer cell alloreactivity for leukemia therapy. J Immunother 2005; 28: 175–182.
Vianello F, Dazzi F . Mesenchymal stem cells for graft-versus-host disease: a double edged sword? Leukemia 2008; 22: 463–465.
Willemze R, Rodrigues CA, Labopin M, Sanz G, Michel G, Socié G et al. KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute Leukemia. Leukemia 2009 (e-pub ahead of print 8 January 2009; doi:10.1038/leu.2008.365).
Acknowledgements
We gratefully acknowledge the cooperation of Dr Dagmar Sigurdardottir (University of Tübingen, Germany), Dr MA Muñoz-Fernández (Laboratory of Immuno-molecular Biology, Hospital General Universitario Gregorio Marañón, Madrid, Spain), Dr M Morado and Dr FH Navarro (Service of Hematology and Hemotherapy, Hospital La Paz, Madrid, Spain) and Dr M Ramirez (Hospital Niño Jesús, Madrid, Spain) who respectively provided the Biotinylated CMV-specific monomers, a plasmid including a fragment of 375 bp of the sjTRECs sequence and the samples from children used in this study. We also gratefully acknowledge the technical assistance of Alicia Pérez and the cooperation of the technical and nursing staff of the Department of Hematology of Hospital Universitario Puerta de Hierro. Dr S Querol (ANRI, London) is acknowledged for the MLC testing of post-transplant and TPD lymphocytes. CB Banks acknowledged by supplying the transplanted CB units include: Barcelona (Spain), Dusseldorf (Germany), Madrid (Spain), New York (US), Milan (Italy), London (UK), Valencia (Spain), Galicia (Spain), St Louis (US), Bordeaux (France), Bensançon (France) and Arcadia (US). Professor George Delclos (University of Texas, Houston, USA) is gratefully acknowledged for his critical revision of the article. This work is supported by grants from EC (AlloStem IP, contract No 503319), Spanish FIS (PI03/0961 & PI04/2794), Spanish Government (SAF 2002-12793E & SAF 2004/0037E), Comunidad Autónoma de Madrid (SAF 2005-04552), Gabrielle Rich Leukemia Foundation, Vidacord and AlloStem-AirProducts Universidad Autónoma de Madrid Chair.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Martín-Donaire, T., Rico, M., Bautista, G. et al. Immune reconstitution after cord blood transplants supported by coinfusion of mobilized hematopoietic stem cells from a third party donor. Bone Marrow Transplant 44, 213–225 (2009). https://doi.org/10.1038/bmt.2009.15
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2009.15
Keywords
This article is cited by
-
Cord blood transplants supported by unrelated donor CD34+ progenitor cells
Bone Marrow Transplantation (2020)